Revised Geneva Score Calculator
Calculate revised geneva score quickly with our cardiovascular system tool. Get results based on evidence-based formulas with clear explanations.
Revised Geneva Score Calculator
Calculate the Revised Geneva Score for pulmonary embolism (PE) clinical probability assessment. Stratify patients into low, intermediate, or high probability categories to guide diagnostic workup.
Last updated: January 2026Reviewed by NovaCalculator Medical Editorial Team
Calculator
Adjust values & calculateFormula
Variables include age > 65 (+1), previous PE/DVT (+3), recent surgery/fracture (+2), active malignancy (+2), unilateral leg pain (+3), hemoptysis (+2), heart rate 75-94 (+3) or >= 95 (+5), and leg pain on palpation/unilateral edema (+4/+1). Scores 0-3 = low, 4-10 = intermediate, 11+ = high probability.
Last reviewed: January 2026
Worked Examples
Example 1: Low Probability PE Assessment
Example 2: High Probability PE Assessment
Background & Theory
The Revised Geneva Score Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the Revised Geneva Score Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Sources & References
- 1Le Gal G et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score - Annals of Internal Medicine 2006
- 2Klok FA et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism - Archives of Internal Medicine 2008
- 3Konstantinides SV et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism
Formula
Revised Geneva Score = Sum of weighted clinical variables (0-25 points)
Variables include age > 65 (+1), previous PE/DVT (+3), recent surgery/fracture (+2), active malignancy (+2), unilateral leg pain (+3), hemoptysis (+2), heart rate 75-94 (+3) or >= 95 (+5), and leg pain on palpation/unilateral edema (+4/+1). Scores 0-3 = low, 4-10 = intermediate, 11+ = high probability.
Worked Examples
Example 1: Low Probability PE Assessment
Problem: A 55-year-old patient presents with chest pain. No prior VTE history, no recent surgery, no cancer. Heart rate 70 bpm. No leg symptoms or hemoptysis.
Solution: Scoring: Age > 65: No (0 points), Previous PE/DVT: No (0), Recent surgery: No (0), Active cancer: No (0), Unilateral leg pain: No (0), Hemoptysis: No (0), Heart rate 70 < 75: (0 points), Leg palpation pain/edema: No (0).\nTotal Revised Geneva Score = 0\nProbability category: Low (0-3 points)\nPE prevalence in this group: approximately 8%
Result: Score: 0/25 | Low Probability | Recommend D-dimer testing; if negative, PE excluded
Example 2: High Probability PE Assessment
Problem: A 72-year-old patient with prior DVT, active lung cancer, heart rate 100 bpm, unilateral leg swelling with pain on palpation, and recent hemoptysis.
Solution: Scoring: Age > 65: Yes (+1), Previous PE/DVT: Yes (+3), Recent surgery: No (0), Active cancer: Yes (+2), Unilateral leg pain: Yes (+3), Hemoptysis: Yes (+2), Heart rate >= 95: (+5), Leg palpation pain + edema: Yes (+4 + 1 = +5).\nTotal Revised Geneva Score = 1+3+2+3+2+5+5 = 21\nProbability category: High (> 10 points)\nPE prevalence in this group: approximately 74%
Result: Score: 21/25 | High Probability | Proceed directly to CTPA; consider empiric anticoagulation
Frequently Asked Questions
What is the Revised Geneva Score and what does it assess?
The Revised Geneva Score is a validated clinical prediction rule used to estimate the pretest probability of pulmonary embolism (PE) in patients presenting with suspected PE symptoms. Originally developed in 2006 by Le Gal and colleagues, it was designed to simplify the original Geneva Score while maintaining diagnostic accuracy. The score uses eight clinical variables that are entirely objective, meaning they do not require subjective clinical assessment. This objectivity is a major advantage over the Wells Score, which includes a somewhat subjective criterion. The Revised Geneva Score stratifies patients into low, intermediate, and high probability categories, guiding subsequent diagnostic workup decisions including D-dimer testing and CT pulmonary angiography.
How does the Revised Geneva Score differ from the Wells Score for PE?
Both the Revised Geneva Score and the Wells Score are clinical prediction rules for pulmonary embolism, but they differ in important ways. The Wells Score includes a subjective criterion asking whether PE is the most likely diagnosis, which can introduce variability between clinicians. The Revised Geneva Score uses only objective, standardized variables, making it more reproducible across different healthcare providers and settings. The Wells Score uses a two-tier (PE likely/unlikely) or three-tier (low/moderate/high) system, while the Revised Geneva Score uses three probability levels. Studies comparing both scores show similar overall diagnostic accuracy, with c-statistics around 0.70 to 0.75 for each. Many clinicians prefer the Revised Geneva Score for research settings due to its objectivity, while the Wells Score remains popular in clinical practice.
What clinical variables are included in the Revised Geneva Score?
The Revised Geneva Score evaluates eight clinical variables. Age over 65 years adds 1 point. Previous history of pulmonary embolism or deep vein thrombosis adds 3 points. Surgery under general anesthesia or lower limb fracture within the past month adds 2 points. Active malignant condition (solid or hematologic, currently active or considered cured for less than one year) adds 2 points. Unilateral lower limb pain adds 3 points. Hemoptysis (coughing up blood) adds 2 points. Heart rate between 75 and 94 beats per minute adds 3 points, while a heart rate of 95 or above adds 5 points. Pain on lower limb deep venous palpation and unilateral edema adds 4 points. The maximum possible score is 25 points.
How should D-dimer testing be interpreted alongside the Geneva Score results?
D-dimer testing plays a crucial role in the diagnostic algorithm when combined with the Revised Geneva Score. For patients with a low probability score (0 to 3 points), a negative D-dimer test can safely exclude pulmonary embolism without further imaging, as the negative predictive value exceeds 99 percent in this group. For intermediate probability patients (4 to 10 points), D-dimer testing is recommended as the next step because imaging all these patients would be costly and expose many to unnecessary radiation. A positive D-dimer in this group warrants CT pulmonary angiography. For high probability patients (11 or more points), D-dimer testing is generally not recommended because the clinical suspicion is high enough to warrant direct imaging, and a negative D-dimer cannot reliably exclude PE in this group.
What are the limitations of the Revised Geneva Score in clinical practice?
The Revised Geneva Score has several important limitations that clinicians should understand. It was primarily validated in emergency department populations and may not perform as well in outpatient or critically ill inpatient settings. The score does not account for certain risk factors such as hormonal contraceptive use, recent long-distance travel, thrombophilia, or obesity, which can influence PE probability. In pregnant patients, the score has not been adequately validated and should be used with extreme caution. The score may also underestimate risk in younger patients with significant risk factors because age contributes only one point. Additionally, the heart rate criterion can be affected by medications such as beta-blockers or conditions causing tachycardia unrelated to PE, potentially leading to misclassification.
How does heart rate influence the Revised Geneva Score and why is it weighted heavily?
Heart rate is one of the most heavily weighted variables in the Revised Geneva Score, contributing up to 5 points for rates at or above 95 beats per minute. This heavy weighting reflects the strong physiological relationship between pulmonary embolism and tachycardia. When a blood clot obstructs pulmonary arteries, the right ventricle must work harder to pump blood through the remaining patent vessels, leading to increased heart rate as a compensatory mechanism. Additionally, PE triggers sympathetic nervous system activation due to hypoxemia and hemodynamic stress. Research shows that tachycardia is present in approximately 40 to 50 percent of patients with confirmed PE, making it one of the most common clinical signs. However, clinicians must recognize that tachycardia has many causes, and its presence alone is neither sensitive nor specific enough for PE diagnosis.
References
- Le Gal G et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score - Annals of Internal Medicine 2006
- Klok FA et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism - Archives of Internal Medicine 2008
- Konstantinides SV et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy